Articles tagged with Inflammation
Researchers found glycerin, a natural ingredient in many skin lotions, reduces psoriasis symptoms by calming scaly patches and promoting healthy skin cell maturation. The study's results support anecdotal reports from patients with psoriasis, providing objective evidence of glycerin's effectiveness in combatting the condition.
A recent study found that pediatric patients with Multisystem Inflammatory Syndrome (MIS-C) who received initial IVIG plus Infliximab had improved cardiac outcomes, reduced need for additional therapies, and faster resolution of inflammation. The updated care pathway recommends this intensified therapy for all MIS-C patients.
A new treatment approach targets angiogenesis, inflammation, and oxidative stress in glioblastoma multiforme, reducing tumor volume and growth by up to 89%. The combination of LAU-0901, Elovanoids, and Avastin shows promise in improving survival rates for patients with this deadly cancer.
Researchers have discovered toxic DNA buildup in the eyes of patients with geographic atrophy, a devastating form of age-related macular degeneration. Common HIV drugs or safer alternatives, such as Kamuvudines, may block inflammation and protect against retinal cell death, offering new hope for treatment.
A clinical trial conducted by TTUHSC researchers found that corneal epithelial stem cell-derived eye drops significantly improved symptoms of severe dry eye disease, with patients experiencing a 23% improvement in SPEED questionnaire scores and a 17.1% improvement in OSDI scores. No adverse reactions were reported during the 12-week tr...
Researchers have found that synthetic bile acid Nor-UDCA directly affects the immune system and reduces inflammation in chronic-inflammatory liver disease. The therapy also guides misdirected CD8-T cells back onto their correct path, allowing them to resume their normal function.
A team of international researchers has unraveled the inner workings of C5aR2, a key receptor involved in inflammation and COVID-19. The study provides an additional opportunity for therapeutic targeting with new drug molecules to block its activation and inflammation response.
A study found that 73% of hospitalized COVID-19 patients developed delirium, leading to lasting cognitive impairment and increased need for skilled nursing care. The disease itself, sedatives, and inflammation can contribute to this outcome.
A common blood test could identify patients with schizophrenia at high risk for cardiovascular disease, enabling early intervention. Elevated white blood cell counts are suspected to be a signal, and a large-scale analysis of over 20,000 patients will examine its associations.
A new gene delivery system promotes healing in rat models by preventing inflammation and bone degradation after tooth replantation. The study found that teeth treated with the system showed significantly greater dental root thickness and fewer osteoclasts, leading to improved success rates.
A large-scale trial will assess the effects of cocoa supplements and multivitamins on aging, including inflammatory factors and genetic changes. Researchers aim to determine if cocoa consumption can reduce age-related health issues such as heart disease, stroke, and cancer.
Researchers have found that blocking DHPS, an enzyme necessary for activating elF5A, can reduce inflammation and improve glucose control in mice. The study suggests macrophages play a key role in inflammation in obesity, and targeting this pathway may be a promising approach to treating the condition.
A biomedical sciences researcher is studying the impact of environment on gut microbiota, immunity, and inflammation in a novel mouse model system. The goal is to define changes in the gut microbiota and mucosal immune system in relation to intestinal inflammation and colon cancer.
Researchers at Nanyang Technological University have developed a 3D model of the human artery blood vessel wall to study atherosclerosis. The model, called an 'arterial wall-on-a-chip', helps understand how cholesterol and inflammatory cells contribute to the disease.
A study of 68 patients found that most had good long-term outcomes with minimal complications, while others faced significant risks. The research provides insights into the potential consequences of COVID-19 multisystem inflammatory syndrome in children.
The study found that patients with low risk of exacerbations do not benefit from low to moderate dose inhaled corticosteroids, while high doses are associated with severe side effects. Tailoring treatment according to patient characteristics, such as age and blood cell count, can minimize over- and underuse of inhaled corticosteroids.
A study published in the Journal of Clinical Investigation found that infection triggers the expression of a protein called IL-33, leading to overgrowth of air spaces and increased mucus production. The researchers suggest that blocking this process could prevent chronic lung damage caused by viral infections.
A study published in the Journal of Clinical Investigation has identified an enzyme called secreted phospholipase A2 group IIA as a key mechanism driving COVID-19 severity. The enzyme is found to be associated with increased mortality rates, particularly when its levels are high, and could provide a new therapeutic target for reducing ...
A multicenter randomized trial showed acupuncture improved symptoms of moderate to severe CP/CPPS, with effects lasting over 24 weeks. Acupuncture was more effective than sham therapy in reducing symptoms and improving quality of life for men with chronic prostatitis/chronic pelvic pain syndrome.
Researchers found that prostaglandin E2 protects epithelial cells from cell death by binding to EP4 receptors. This activation counteracts intestinal inflammation progression and may prevent bacterial penetration.
Researchers review advancements in biosensing technologies for neonatal sepsis diagnosis, highlighting the need for faster and more accurate methods. Biosensors offer a promising solution, detecting multiple parameters simultaneously with high sensitivity and accuracy.
A University at Buffalo-led study found that photobiomodulation therapy sped up recovery from burns and reduced inflammation in mice by activating endogenous TGF‐beta 1, a protein controlling cell growth and division. The findings may improve therapeutic treatments for burn injuries worldwide.
A study from the University of South Carolina's Environmental Health & Disease Laboratory found that andrographolide successfully restored bacteriomes and viromes, increasing beneficial bacteria and decreasing harmful bacteria. The treatment also decreased gut inflammation and neuroinflammation in veterans with Gulf War Illness.
A new process for making RNA has been developed by researchers at the University of Massachusetts Amherst, yielding purer and more abundant RNA at a fraction of the cost. This breakthrough removes the largest stumbling block on the path to next-generation RNA therapeutic drugs.
Researchers from Tokyo Medical and Dental University found that IgA deficiency causes substantial inflammation in the ileum of mice, making them susceptible to disease. The study reveals IgA plays a protective role in maintaining gut health by regulating microorganisms.
Researchers studied inflammation's role in scarring of the central nervous system in three diseases: multiple sclerosis, aquaporin-4 antibody positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody associated disorder. In MS, scars lead to nerve fiber degeneration and slow worsening of disabili...
Researchers found that early-life inflammation weakens the brain's ability to cope with stress, leading to adolescent depression. Microglial cells overengage with neurons, reducing glutamatergic neuronal activity.
Research suggests that telomere shortening drives intestinal inflammation in inflammatory bowel disease (IBD). Telomere erosion is positively associated with disease severity and may underlie disease recurrence.
A new experimental model using human stem cells successfully tested the impact of a next-generation anti-inflammatory drug on the brain's blood-brain barrier. The results showed that the breakdown of the barrier is more complex than previously thought and can be prevented with antioxidants.
The European Alliance of Associations for Rheumatology taskforce provides guidelines for treating severe COVID-19 with immunomodulatory therapies. The recommendations consider the individual's condition and stage of the disease, including antiviral medicines, oxygen therapy, and anticoagulation.
A new study reveals that common OTC drugs for sore throat are more harm than good, causing inflammation and damage to upper respiratory cells. Biovanta, a naturally derived drug, has been shown to reduce inflammation and treat respiratory inflammation effectively.
This autopsy study investigated skeletal muscle and myocardial inflammation in patients with COVID-19, compared to those dying from other causes. The findings suggest distinct inflammatory patterns in the two groups, which may help explain COVID-19 severity and mortality.
A study found that the Tsimane indigenous people have slower brain atrophy than Westerners, suggesting their physically active lifestyle and high-fiber diet may hold the key to slowing down aging. The researchers enrolled 746 Tsimane adults in their study and compared their brain volumes with those in three industrialized populations.
New research suggests that anti-cancer therapies can hasten cellular aging, leading to increased inflammation and fatigue in patients with head and neck cancer. Epigenetic changes associated with these treatments may contribute to age-related conditions.
A new study published in the Journal of the American College of Cardiology found that a diet proven to lower elevated blood pressure, known as the DASH diet, reduces inflammation and heart injury. The findings also showed that a low-sodium diet can improve cardiovascular risk factors in a relatively short time period.
A new study from Rice University found that widowed spouses with higher levels of bodily inflammation experienced more severe symptoms of depression three months later. The researchers identified a potential biomarker to predict who is at greatest risk for long-term repercussions of loss.
The VOYAGE study found that dupilumab reduced asthma exacerbations by 59.3% in children with uncontrolled moderate-to-severe asthma. The treatment also improved lung function within two weeks, an effect sustained for up to 52 weeks.
Researchers at Newcastle University discovered that tiny pieces of genetic material, miR-424-5p, increase in early stages of heart disease in type 1 diabetes patients. This biomarker has the potential to define additional therapeutic options to help patients with type 1 diabetes.
Researchers created a detailed cell atlas of COVID lungs, revealing a trifecta of detrimental effects: runaway inflammation, direct destruction, and impaired regeneration of lung cells involved in gas exchange. This study provides leads on why survivors experience long-term respiratory complications due to lung scarring.
A new study published in PLOS Pathogens found that mice fed a Western-style diet high in processed foods and low in fiber developed persistent infections that led to inflammation and insulin resistance. The researchers suggest that altering gut microbiota through diet may be a means of promoting health.
Recent studies point to links between environmental exposures and health risks, including respiratory problems from hog farms and inflammation caused by triclosan. Gulf War veterans may also be more susceptible to alcohol-induced liver damage due to environmental factors.
A new study in Arthritis & Rheumatology identifies specific blood markers to distinguish excessive COVID-19 inflammation from cytokine storm syndromes. This finding has significant implications for treating critically ill patients with COVID-19.
Researchers found that probiotic Lactobacillus acidophilus strain LA1 generates a rapid and sustained enhancement of the intestinal barrier, effectively treating intestinal inflammation. The study also showed that LA1 can prevent colonic inflammation formation and promote healing in mice with induced colitis.
Researchers identified serum amyloid A (SAA) as a potential biomarker for COVID-19 risk, with higher levels associated with increased inflammation, clot abnormalities, and organ damage. This biomarker could help facilitate early identification of patients requiring aggressive management and monitoring.
A new positron emission tomography (PET) tracer targeting inflammation has been shown to be safe and effective in identifying early stages of rheumatoid arthritis. The tracer rapidly clears from blood circulation and has a low radiation dose, making it suitable for patient imaging studies.
Researchers at CNIO discover that digoxin, a drug used for heart diseases, reduces inflammation and leads to significant weight loss in obese mice. The study identifies IL-17A as a causal factor of obesity, suggesting a potential therapeutic option for treating the inflammatory disease.
Researchers from NUST MISIS have created innovative multilayer coatings that synthesizes protective properties of nanoparticles, biopolymers, anticoagulants, and antibiotics. The coatings demonstrated excellent bactericidal efficacy against antibiotic-resistant bacterial strains with a prolonged antibacterial effect up to 7 days.
A recent Finnish study found that accumulating brisk and vigorous physical activity can curb adiposity-induced low-grade inflammation in children. The study, conducted among researchers from Finland and the UK, also reported no independent association between diet quality and low-grade inflammation.
COVID-19 survivors may experience blood clots due to a lingering immune response that damages blood vessels. The study found twice as many damaged blood vessel cells in COVID-19 survivors compared to healthy individuals.
Researchers investigating COVID-19's impact on the thyroid gland found atypical inflammation in 1/3 of patients after 3 months, raising concerns about potential long-term damage. The study aims to determine if this inflammation triggers permanent thyroid dysfunction.
A four-year federal grant of over $2 million is being awarded to Dr. Andrew Gewirtz at Georgia State University to investigate the role of inflammation and altered gut microbiota in the development of metabolic syndrome.
Researchers found that prenatal stress leads to significant inflammation in the fetal brain, but surprisingly, the mother's placenta and uterus remain unactivated. Instead, stress reduces gut microbial strains and functions, especially those linked to inflammation.
The Medical University of South Carolina has enrolled children with multisystem inflammatory syndrome in children (MIS-C) in a trial of remestemcel-L, a novel cellular therapy. The treatment showed significant improvement within 24 hours for two patients, offering hope for better management of the rare but life-threatening condition.
A UMass Amherst study found a positive linear relationship between tobacco smoking intensity and duration with inflammation in HIV-positive individuals. The researchers suggest that people living with HIV would benefit from quitting or reducing smoking to lower inflammation levels, which are linked to increased disease risk.
Researchers at RCSI University of Medicine and Health Sciences have discovered a new way to halt excessive inflammation by regulating Arginase-2, a protein that limits inflammatory cytokine production. This breakthrough has the potential to protect the body from tissue damage caused by inflammatory diseases.
A large-scale study published in JAMA Cardiology found that inflammatory heart disease is rare among professional athletes with mild or asymptomatic COVID-19 infection. Only five out of 789 athletes developed heart inflammation, indicating a very low incidence of heart risk after mild COVID-19.
Researchers identified three patient segments based on blood lymphocyte counts and PET/CT scan findings, indicating varying levels of disease activity. The discovery could help guide treatment and understand the underlying mechanisms associated with sarcoidosis.
Researchers at WashU Medicine have found a new way to block chronic lung diseases such as asthma and COPD by targeting the packaging of inflammatory cytokines in exosomes. By blocking the release of these packaged cytokines, they can prevent damage to the lungs and slow disease progression in mice.
Researchers identified a mechanism linking acrolein accumulation to glycocalyx modifications, damaging the blood-brain barrier. The study suggests that acrolein-modified proHPSE could be a novel drug target for post-stroke inflammation.
A new study published in Nature Communications found that high fructose diets can cause the immune system to become inflamed, leading to damage and increasing the risk of disease. The research also suggests a link between fructose consumption and obesity, type 2 diabetes, and non-alcoholic fatty liver disease.